Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH3D

Levofloxacin

PubChem 149096
was used by NIH 3D workflows to automatically generate models for
Kzoghebi
Created:
9/30/19
Submitted:
10/8/26
Published:
10/8/26

Select an image below to view

Learn more about NIH 3D workflow outputs

3DPX-012054

Licensing:

CC-BY
334
20
Version 3

Category

Small Molecules
Small Molecules
Description

Levofloxacin is an optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase. It has a role as an antibacterial drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a topoisomerase IV inhibitor and a DNA synthesis inhibitor. It is a 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, a quinolone antibiotic and a fluoroquinolone antibiotic. It is a conjugate acid of a levofloxacin(1-). It is an enantiomer of a dextrofloxacin.
https://pubchem.ncbi.nlm.nih.gov/image/imagefly.cgi?cid=149096&width=400&height=400